AstraZeneca PLC (AZN) vs Elevance Health Inc. (ELV)
A side-by-side comparison of AstraZeneca PLC and Elevance Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
AZN
AstraZeneca PLC
$172.48HealthcareDelayed quote: Jul 28, 2026, 7:53 PM EDT
ELV
Elevance Health Inc.
$385.73HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — AZN vs ELV
growth of $100 · dividends reinvested · last 25yAZN +783.6%ELV +2205.3%ELV compounded faster
AZN ELV
AZN vs ELV: by the numbers
- •AZN is the larger company ($133.67B vs $83.65B market cap).
- •AZN trades at the lower trailing earnings multiple (12.77 vs 16.82 P/E), one valuation lens rather than an overall verdict.
- •AZN converts more revenue to profit (17.19% vs 2.47% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 9.25% CAGR).
- •AZN pays the higher dividend yield (1.89% vs 1.81%).
Metrics side by side
Valuation
| Metric | AZN | ELV |
|---|---|---|
| P/E ratio | 12.77 | 16.82 |
| Forward P/E | 16.58 | 13.95 |
| P/S ratio | 2.19 | 0.41 |
| P/B ratio | 2.80 | 1.84 |
| PEG ratio | 0.29 | 2.52 |
| EV / EBITDA | 7.89 | 12.78 |
| FCF yield | 6.09% | 7.63% |
Profitability
| Metric | AZN | ELV |
|---|---|---|
| Gross margin | 81.68% | 25.56% |
| Operating margin | 23.69% | 3.51% |
| Net margin | 17.19% | 2.47% |
| ROE | 21.95% | 11.06% |
| ROIC | 13.03% | 6.65% |
Dividends
| Metric | AZN | ELV |
|---|---|---|
| Dividend yield | 1.89% | 1.81% |
| Payout ratio | 24.24% | 27.24% |
Growth (annualized)
| Metric | AZN | ELV |
|---|---|---|
| Revenue CAGR (5Y) | 16.99% | 9.25% |
| EPS CAGR (5Y) | 22.02% | 6.67% |
| FCF CAGR (5Y) | 15.68% | -19.97% |
| Total return CAGR (5Y) | 10.56% | 1.14% |
Frequently asked
- Which has the lower trailing P/E, AZN or ELV?
- AZN has the lower trailing P/E: AZN trades at 12.77 and ELV at 16.82. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, AZN or ELV?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus ELV at 9.25%.
- Does AZN or ELV pay a bigger dividend?
- AZN yields 1.89% and ELV yields 1.81% based on trailing dividends and the latest price.
- Is AZN or ELV more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus ELV at 2.47%.
- How have AZN and ELV total returns compared?
- Over the past 10 years, AZN delivered 13.96% and ELV delivered 12.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioElevance Health P/E ratioAstraZeneca dividend yieldElevance Health dividend yieldAstraZeneca ROEElevance Health ROEAstraZeneca operating marginElevance Health operating marginAstraZeneca revenue growthElevance Health revenue growthAstraZeneca free cash flowElevance Health free cash flow
AstraZeneca & Elevance Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.